Immunogenicity and Safety Study in Infants of GlaxoSmithKline Biologicals' Infanrix Hexa™ (DTPa-HBV-IPV/Hib) Vaccine

NCT01353703 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

224

Enrollment

INDUSTRY

Sponsor class

Conditions

Poliomyelitis
Tetanus
Acellular Pertussis
Haemophilus Influenzae Type b
Diphtheria
Hepatitis B
Diphtheria-Tetanus-aPertussis-Hepatitis B-Poliomyelitis-Haemophilus Influenzae Type b Vaccines

Interventions

BIOLOGICAL: Infanrix hexa™

Sponsor

GlaxoSmithKline